She has performed several laboratory-developed test validations and has experience with many different manufacturers in molecular diagnostic testing. Millner has been the director of high complexity laboratories and served as a consultant for numerous labs since 2015. Millner has several peer-reviewed and published manuscripts and has won numerous awards for her research including the Young Investigator Award and Best Abstract Award from the American Association of Clinical Chemists and the Young Scientist Award (Innovator in Science) from the Association of Clinical Scientists. During the fellowship, she also continued her research on CTCs and was the lead author on a funded SBIR grant.ĭr. Millner was trained to be a Laboratory Director and responded to over 200 beeper calls and physician inquiries in the University of Louisville Hospital’s high complexity laboratory. In 2012, she entered a 3-year COMACC accredited fellowship in Clinical Chemistry and Toxicology at the University of Louisville Hospital Laboratory. Following completion of her doctorate, she completed a one-year postdoctoral fellowship where she researched Circulating Tumor Cells (CTCs) and cell-free nucleic acid (cfNA). Huang Outstanding Graduate Student of the Year Award and the Dean’s Citation. Her dissertation focused on the characterization of phase II metabolic enzyme, N-acetyltransferase, for which she received the K. in 2011 from the University of Louisville in Pharmacology and Toxicology. Thereafter, she worked as a Lead Geneticist for three years in a CAP-accredited lab.ĭr. degree in Pharmaceutical Sciences major from North Dakota State University in the year 2014. She is also assisting labs with Emergency Use Authorization paperwork and submission to the FDA. She has helped new labs with setup, test panel design, method validation, data analysis, reporting, and documentation.Ĭurrently, she has been assisting labs with the development and validation of the PCR-based SARS-COVID-2 test. Meghnani has provided turn-key solutions to new independent reference laboratories and physician’s office laboratories. Toxicology, Allergy testing, Molecular Diagnostics, etc. Meghnani has directed and audited many CAP, CLIA, COLA labs with a variety of test menus i.e. Meghnani has been managing overall operations and compliance of clinical labs across the nation. UTI treatment and management cost billions of health care dollars annually in both the ambulatory and the inpatient setting. An estimated 60 of women will experience at least one UTI in their lifetime. Varsha Meghnani is a board-certified Clinical lab director with more than 10 years of experience in Molecular diagnostic tests that include but not limited to Pharmacogenomics, Cancer Genomics, infectious disease, and inherited disease tests. Urinary tract infection (UTI) is one of the most common types of bacterial infections in adults.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |